王宁,程冠良,王亮,杨泉,张文超

• 1:北京大学国际医院心血管内科

摘要(Abstract)：

目的 分析桡动脉止血器在经肱动脉冠状动脉介入术中应用的安全性和有效性。方法 回顾性分析2018年1月1日至2023年12月31日在北京大学国际医院接受经肱动脉入路冠状动脉介入诊疗的患者。根据术后止血方式将其分为桡动脉止血器组（170例）和常规压迫组（100例），比较两组间穿刺点周围出血并发症发生率及临床特征。结果 经肱动脉入路冠状动脉介入治疗患者共270例，共出现18例并发症，其中穿刺点周围出血17例（16例为轻微出血，1例为严重出血），一过性正中神经损伤1例，整体并发症发生率为6.7%，穿刺点周围出血发生率为6.3%。桡动脉止血器组出血发生率为5.9%，常规压迫组为7.0%，两组差异无统计学意义（P=0.715）。多因素回归分析提示女性为穿刺点周围出血的独立危险因素（OR 4.57,95%CI 1.40～14.96,P=0.012）。随着技术积累，经肱动脉入路及桡动脉止血器的应用逐年增加（均P<0.010）。结论 桡动脉止血器在经肱动脉冠状动脉介入中可有效止血，具备较好安全性，其简便性和有效性为经肱动脉入路止血提供了新的处理策略。

关键词(KeyWords)： 肱动脉;经皮冠状动脉介入治疗;桡动脉止血器

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金项目（81970275）

作者(Author): 王宁,程冠良,王亮,杨泉,张文超

参考文献(References)：

• [1]Ghanem I,Mesbah M,Refaat H.Safety and efficacy of brachial approach for coronary angiography and percutaneous coronary intervention[J].Egypt Heart J,2024,76(1):36.DOI:10.1186/s43044-024-00466-6.
• [2]Mele M,Mele A,Cuculo A,et al.How brachial a c c e s s compares to femoral access for invasive cardiac angiography when radial access is not feasible:a meta-analysis[J].J Vasc Access,2024,25(4):1063-1068.DOI:10.1177/11297298221145752.
• [3]Sachdeva S,Saha S.Transradial approach to cardiovascular interventions:an update[J].Int J Angiol,2014,23(2):77-84.DOI:10.1055/s-0034-1372243.
• [4]Romagnoli E,Biondi-Zoccai G,Sciahbasi A,et al.Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome:the RIFLE-STEACS(Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) study[J].J Am Coll Cardiol,2012,60(24):2481-2489.DOI:10.1016/j.jacc.2012.06.017.
• [5]蔡梦阳，夏晴，章慧慧等.经远端桡动脉路径在冠心病诊疗中的研究进展及展望[J].中国介入心脏病学杂志，2024,32(7):390-395.DOI:10.3969/j.issn.1004-8812.2024.07.004.
• [6]Valgimigli M,Gagnor A,CalabróP,et al.Radial v e r s u s femoral access in patients with acute coronary syndromes undergoing invasive management:a randomised multicentre trial[J].Lancet,2015,385(9986):2465-2476.DOI:10.1016/s0140-6736(15)60292-6.
• [7]Basche S,Eger C,Aschenbach R.Transbrachial angiography:an eff ective and safe approach[J].VASA,2004,33(4):231-234.DOI:10.1024/0301-1526.33.4.231.
• [8]Brueck M,Bandorski D,Kramer W,et al.A randomized comparison of transradial versus transfemoral approach for coronary angiography and angioplasty[J].JACC Cardiovasc I n t e r v,2 0 0 9,2 (11):1 0 4 7-1 0 5 4.D O I:1 0.1 0 1 6/j.jcin.2009.07.016.
• [9]Sherev DA,Shaw RE,Brent BN.Angiographic predictors of femoral access site complications:implication for planned percutaneous coronary intervention[J].Catheter Cardiovasc Interv,2005,65(2):196-202.DOI:10.1002/ccd.20354.
• [10]Sones FM Jr,Shirey EK.Cine coronary arteriography[J].Mod Concepts Cardiovasc Dis,1962,31:735-738.
• [11]Hildick-smith DJ,Khan ZI,Shapiro LM,et al.Occasionaloperator percutaneous brachial coronary angiography:fi rst,do no arm[J].Catheter Cardiovasc Interv,2002,57(2):161-166.DOI:10.1002/ccd.10329.
• [12]Kiemeneij F,Laarman GJ,Odekerken D,et al.A randomized comparison of percutaneous transluminal coronary angioplasty by the radial,brachial and femoral approaches:the access study[J].J Am Coll Cardiol,1997,29(6):1269-1275.DOI:10.1016/s0735-1097(97)00064-8.
• [13]Petrov I,Stankov Z,Tasheva I,et al.Safety and effi cacy of transbrachial access for endovascular procedures:a single-center retrospective analysis[J].Cardiovasc Revasc Med,2020,21(10):1269-1273.DOI:10.1016/j.carrev.2020.02.023.
• [14]Parviz Y,Rowe R,Vijayan S,et al.Percutaneous brachial artery access for coronary artery procedures:feasible and safe in the current era[J].Cardiovasc Revasc Med,2015,16(8):447-449.DOI:10.1016/j.carrev.2015.08.004.
• [15]张彬，梁磊，崔美平，等.经肱动脉入径行经皮冠状动脉介入治疗术后拔除鞘管时间与并发症相关性的研究[J].中国介入心脏病学杂志，2015,23(12):682-684.DOI:10.3969/j.issn.1004-8812.2015.12.005.
• [16]Aijaz S,Sheikh S,Pathan A.Combination of Inno SEALplus TR band compared with TR band alone for radial artery outcomes in patients undergoing transradial coronary intervention(Inno SEAL-Ⅱ）：an open-label randomised controlled trial(protocol)[J].BMJ open,2020,10(12):e042101.DOI:10.1136/bmjopen-2020-042101.
• [17]Shroff AR,Fernandez C,Vidovich MI,et al.Contemporary transradial access practices:results of the second international survey[J].Catheter Cardiovasc Interv,2019,93(7):1276-1287.DOI:10.1002/ccd.27989.
• [18]Feit F,Voeltz MD,Attubato MJ,et al.Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 Trial[J].Am J Cardiol,2007,100(9):1364-1369.DOI:10.1016/j.amjcard.2007.06.026.
• [19]Aguirre FV,Topol EJ,Ferguson JJ,et al.Bleeding complications with the chimeric antibody to platelet glycoproteinⅡb/Ⅲa integrin in patients undergoing percutaneous coronary intervention.EPIC Investigators[J].Circulation,1995,91(12):2882-2890.DOI:10.1161/01.cir.91.12.2882.